Quick Answer
Amneal Pharmaceuticals, Inc. reported Total Revenue of $3.02 billion for fiscal year 2025.
Amneal Pharmaceuticals, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $3.02B | +8.0% |
| 2024 | $2.79B | +16.7% |
| 2023 | $2.39B | +8.2% |
| 2022 | $2.21B | +5.7% |
| 2021 | $2.09B | +5.1% |
| 2020 | $1.99B | +22.5% |
| 2019 | $1.63B | -2.2% |
| 2018 | $1.66B | +60.9% |
| 2017 | $1.03B | +1.5% |
| 2016 | $1.02B | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $784.51M | +11.7% | +8.3% |
| June 30, 2025 | $724.51M | +3.2% | +4.2% |
| March 31, 2025 | $695.42M | +5.5% | -1.0% |
| September 30, 2024 | $702.47M | +13.3% | +0.1% |
| June 30, 2024 | $701.78M | +17.1% | +6.5% |
| March 31, 2024 | $659.19M | +18.2% | +6.3% |
| September 30, 2023 | $620.04M | +13.7% | +3.5% |
| June 30, 2023 | $599.05M | +7.1% | +7.4% |
- Amneal Pharmaceuticals, Inc. showed an increase of +8.0% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2025 period, Amneal Pharmaceuticals, Inc.’s total revenue has grown by 196.5% (from $1.02 billion to $3.02 billion).
- The most recent figure is from Amneal Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: